The Distribution of Immunoglobulin Isotype in Polyclonal Hypergammaglobulinemia in Systemic and Autoimmune Diseases

Recruiting Observational Study
Polyclonal Hypergammaglobulinemia Autoimmune Diseases
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
150 (estimated)
Sponsor
Centre Hospitalier Universitaire, Amiens · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Polyclonal hypergammaglobulinaemia is characterized by increased levels of immunoglobulins and is a common feature observed in various diseases such as autoimmune diseases, chronic infectious diseases or lymphoid hemopathy. Some autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis or Sjögren's syndrome are frequently associated with polyclonal hypergammaglobulinaemia. Rec…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * All adult patients \> 18 years old * patients with one of the following diseases: systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome, autoimmune hepatitis, sarcoidosis or lymphoma. Exclusion Criteria: * Age \< 18 years; * chronic viral hepatitis; * HIV in…
Contacts

Valéry Salle, MD

03 22 66 82 30

salle.valery@chu-amiens.fr

CONTACT